DAPAGLIFLOZIN: NEWER MOLECULE FOR TREATMENT OF TYPE 2 DIABETES MELLITUSType 2 diabetes mellitus is a common chronic disease that causes significant morbidity and mortality worldwide. Diabetes results from a combination of increased hepatic glucose product. Int. Res. J. Pharm. 2024;2(1):32-40. Accessed August 24, 2026. https://irjponline.org/index.php/irjp/article/view/1741